{
    "clinical_study": {
        "@rank": "95891", 
        "arm_group": {
            "arm_group_label": "Duchenne and Becker Muscular Dystrophy", 
            "description": "Patients with Duchenne or Becker Muscular Dystrophy, as well as carrier females."
        }, 
        "brief_summary": {
            "textblock": "DuchenneConnect is an online, patient-report registry for individuals with Duchenne and\n      Becker muscular dystrophy and carrier females. The purpose of DuchenneConnect is to connect\n      Duchenne and Becker patients with actively recruiting clinical trials and research studies,\n      and to educate patients and families about Duchenne and Becker care and research.  At the\n      same time, DuchenneConnect is a valuable resource for clinicians and researchers in academia\n      and industry, allowing access to a de-identified, aggregate dataset provided by patients and\n      their families\u2014information that is vital to advances in the care and treatment of Duchenne."
        }, 
        "brief_title": "DuchenneConnect Registry", 
        "completion_date": {
            "#text": "October 2047", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Duchenne Muscular Dystrophy", 
            "Becker Muscular Dystrophy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Muscular Dystrophy, Duchenne", 
                "Muscular Dystrophies"
            ]
        }, 
        "detailed_description": {
            "textblock": "DuchenneConnect was created in 2007 by Parent Project Muscular Dystrophy (PPMD), with\n      assistance from the NIH, the CDC, and Emory Genetics. In early 2011, PPMD alone began\n      financing the registry's operation and maintenance, and is the sole guardian of\n      DuchenneConnect and its material.\n\n      Questions may be addressed to the DuchenneConnect Coordinator at telephone 201.937.1408 or\n      coordinator@duchenneconnect.org.  The DuchenneConnect Coordinator is a certified genetic\n      counselor who is available to answer questions regarding the registration process, genetic\n      testing and counseling, and clinical trials and research studies."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of Duchenne or Becker muscular dystrophy;  Manifesting female carriers and\n             asymptomatic female carriers also included in registry.\n\n        Exclusion Criteria:\n\n          -  Diagnosis of any other type of muscular dystrophy (including limb-girdle muscular\n             dystrophy)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "DuchenneConnect is primarily a United States registry, but we do welcome participants from\n        other countries and we currently have over 100 countries represented in the registry."
            }
        }, 
        "enrollment": {
            "#text": "10000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02069756", 
            "org_study_id": "DC-PPMD-2013"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Duchenne", 
            "Becker", 
            "Muscular Dystrophy"
        ], 
        "lastchanged_date": "February 20, 2014", 
        "link": [
            {
                "description": "DuchenneConnect", 
                "url": "https://www.duchenneconnect.org/"
            }, 
            {
                "description": "TREAT-NMD Neuromuscular Alliance", 
                "url": "http://www.treat-nmd.eu/"
            }, 
            {
                "description": "Parent Project Muscular Dystrophy", 
                "url": "http://www.parentprojectmd.org"
            }
        ], 
        "location": {
            "contact": {
                "email": "coordinator@duchenneconnect.org", 
                "last_name": "Ann Martin, MS, CGC", 
                "phone": "201-937-1408"
            }, 
            "facility": {
                "address": {
                    "city": "Hackensack", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "07601"
                }, 
                "name": "DuchenneConnect / PPMD"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "DuchenneConnect: An International, Patient-Report Registry for Individuals With Duchenne/Becker Muscular Dystrophy (Member of TREAT-NMD Neuromuscular Alliance)", 
        "other_outcome": [
            {
                "description": "Data collected includes whether or not corticosteroids are used, and if so, name of corticosteroid,  age started/stopped, and dosing regimen (daily, weekends, etc).", 
                "measure": "Corticosteroid use", 
                "safety_issue": "No", 
                "time_frame": "Registrants are requested to update their medical history every 12 months, and they will be followed throughout their lifetime."
            }, 
            {
                "description": "Multiple questions regarding cardiovascular symptoms, age at diagnosis of cardiomyopathy, use of cardiac medications, date of most recent echocardiogram and/or cardiac MRI, and the LVEF and/or LVSF value.", 
                "measure": "Cardiovascular status", 
                "safety_issue": "No", 
                "time_frame": "Registrants are requested to update their medical history every 12 months, and they will be followed throughout their lifetime."
            }, 
            {
                "description": "Assessed from questions about use of breathing devices, age at which breathing devices were started, date of most recent pulmonary function test (spirometry), and the FVC value (% predicted and raw FVC in liters).", 
                "measure": "Respiratory status", 
                "safety_issue": "No", 
                "time_frame": "Registrants are requested to update their medical history every 12 months, and they will be followed throughout their lifetime."
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "European Union:  TREAT-NMD Neuromuscular Alliance", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2027", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Genetic mutation data is collected by patient report and verified by curation/review of genetic test report when provided.  Genetic test report is requested for each registrant and is required for participation in global DMD (TREAT-NMD) registry.", 
            "measure": "Genetic mutation", 
            "safety_issue": "No", 
            "time_frame": "Registrants are requested to update their medical history every 12 months, and they will be followed throughout their lifetime."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02069756"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "22453902", 
            "citation": "Rangel V, Martin AS, Peay HL. DuchenneConnect Registry Report. Version 2. PLoS Curr. 2012 Feb 29 [revised 2012 Mar 13];4:RRN1309."
        }, 
        "secondary_outcome": {
            "description": "Ambulation status is assessed from several questions about mobility in home and away from home, ability to sit and stand, use of assistive devices, and age at full time wheelchair use", 
            "measure": "Ambulation status", 
            "safety_issue": "No", 
            "time_frame": "Registrants are requested to update their medical history every 12 months, and they will be followed throughout their lifetime."
        }, 
        "source": "DuchenneConnect", 
        "sponsors": {
            "collaborator": {
                "agency": "Parent Project Muscular Dystrophy", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "DuchenneConnect", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2007", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "40 Years", 
        "verification_date": "February 2014"
    }
}